Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Feb;52(2):248–253. doi: 10.1136/jnnp.52.2.248

The investigation of Alzheimer's disease with single photon emission tomography.

A Burns 1, M P Philpot 1, D C Costa 1, P J Ell 1, R Levy 1
PMCID: PMC1032514  PMID: 2467967

Abstract

Twenty patients satisfying standard clinical criteria for Alzheimer's disease (AD) and six age-matched normal controls were studied using 99mTc hexamethyl-propyleneamine oxime and single photon emission tomography. The AD patients had lower regional cerebral blood flow (rCBF) in the temporal and posterior parietal lobes compared to controls. AD patients with apraxia and aphasia had lower rCBF in the lateral temporal and posterior parietal lobes than AD patients without these features. Within the AD group, correlations were found between neuropsychological tests and rCBF: praxis correlated with posterior parietal activity, memory with left temporal lobe activity and language with activity throughout the left hemisphere.

Full text

PDF
248

Images in this article

249Image
on p.249
251Image
on p.251
251Image
on p.251
252Image
on p.252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson D. F., Kuhl D. E., Hawkins R. A., Phelps M. E., Cummings J. L., Tsai S. Y. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol. 1983 Nov;40(12):711–714. doi: 10.1001/archneur.1983.04050110029003. [DOI] [PubMed] [Google Scholar]
  2. Besson J. A., Corrigan F. M., Foreman E. I., Eastwood L. M., Smith F. W., Ashcroft G. W. Nuclear magnetic resonance (NMR). II. Imaging in dementia. Br J Psychiatry. 1985 Jan;146:31–35. doi: 10.1192/bjp.146.1.31. [DOI] [PubMed] [Google Scholar]
  3. Bonte F. J., Ross E. D., Chehabi H. H., Devous M. D., Sr SPECT study of regional cerebral blood flow in Alzheimer disease. J Comput Assist Tomogr. 1986 Jul-Aug;10(4):579–583. doi: 10.1097/00004728-198607000-00005. [DOI] [PubMed] [Google Scholar]
  4. Cutler N. R., Haxby J. V., Duara R., Grady C. L., Kay A. D., Kessler R. M., Sundaram M., Rapoport S. I. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol. 1985 Sep;18(3):298–309. doi: 10.1002/ana.410180305. [DOI] [PubMed] [Google Scholar]
  5. Ell P. J., Costa D. C., Harrison M. Imaging cerebral damage in HIV infection. Lancet. 1987 Sep 5;2(8558):569–570. doi: 10.1016/s0140-6736(87)92955-2. [DOI] [PubMed] [Google Scholar]
  6. Ell P. J., Jarritt P. H., Cullum I., Hocknell J. M., Costa D. C., Lui D., Jewkes R. F., Steiner T. J., Nowotnik D. P., Pickett R. D. Regular cerebral blood flow mapping with 99mTc-labelled compound. Lancet. 1985 Jul 6;2(8445):50–51. doi: 10.1016/s0140-6736(85)90110-2. [DOI] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Foster N. L., Chase T. N., Fedio P., Patronas N. J., Brooks R. A., Di Chiro G. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology. 1983 Aug;33(8):961–965. doi: 10.1212/wnl.33.8.961. [DOI] [PubMed] [Google Scholar]
  9. Foster N. L., Chase T. N., Mansi L., Brooks R., Fedio P., Patronas N. J., Di Chiro G. Cortical abnormalities in Alzheimer's disease. Ann Neurol. 1984 Dec;16(6):649–654. doi: 10.1002/ana.410160605. [DOI] [PubMed] [Google Scholar]
  10. Frackowiak R. S., Pozzilli C., Legg N. J., Du Boulay G. H., Marshall J., Lenzi G. L., Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981 Dec;104(Pt 4):753–778. doi: 10.1093/brain/104.4.753. [DOI] [PubMed] [Google Scholar]
  11. Friedland R. P., Budinger T. F., Koss E., Ober B. A. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett. 1985 Feb 4;53(3):235–240. doi: 10.1016/0304-3940(85)90543-9. [DOI] [PubMed] [Google Scholar]
  12. Holman B. L., Gibson R. E., Hill T. C., Eckelman W. C., Albert M., Reba R. C. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. JAMA. 1985 Dec 6;254(21):3063–3066. doi: 10.1001/jama.254.21.3063. [DOI] [PubMed] [Google Scholar]
  13. Jacoby R. J., Levy R. Computed tomography in the elderly. 2. Senile dementia: diagnosis and functional impairment. Br J Psychiatry. 1980 Mar;136:256–269. doi: 10.1192/bjp.136.3.256. [DOI] [PubMed] [Google Scholar]
  14. Johnson K. A., Mueller S. T., Walshe T. M., English R. J., Holman B. L. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol. 1987 Feb;44(2):165–168. doi: 10.1001/archneur.1987.00520140035014. [DOI] [PubMed] [Google Scholar]
  15. Koss E., Friedland R. P., Ober B. A., Jagust W. J. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry. 1985 May;142(5):638–640. doi: 10.1176/ajp.142.5.638. [DOI] [PubMed] [Google Scholar]
  16. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  17. Mountjoy C. Q., Rossor M. N., Iversen L. L., Roth M. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain. 1984 Jun;107(Pt 2):507–518. doi: 10.1093/brain/107.2.507. [DOI] [PubMed] [Google Scholar]
  18. Neary D., Snowden J. S., Shields R. A., Burjan A. W., Northen B., MacDermott N., Prescott M. C., Testa H. J. Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry. 1987 Sep;50(9):1101–1109. doi: 10.1136/jnnp.50.9.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984 Mar 31;288(6422):961–964. doi: 10.1136/bmj.288.6422.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986 Dec;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
  21. Seltzer B., Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? Arch Neurol. 1983 Mar;40(3):143–146. doi: 10.1001/archneur.1983.04050030037006. [DOI] [PubMed] [Google Scholar]
  22. Thompson P., Blessed G. Correlation between the 37-item mental test score and abbreviated 10-item mental test score by psychogeriatric day patients. Br J Psychiatry. 1987 Aug;151:206–209. doi: 10.1192/bjp.151.2.206. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES